80+ total transactions representing $1B+ in aggregate value — 14 tracked below spanning 2022–2025 · 4 industries
Exclusive sell-side advisor on the sale of life sciences commercialization consulting firm to market access platform company IntegriChain. Blue Fin Group had 45 consultants and served 300+ manufacturers.
Buy-side advisor to largest independent specialty pharmacy in the U.S. on acquisition of specialty pharmacy focused on infusion therapies.
Financial advisor on recapitalization of leading provider of integrated comprehensive health enhancement programs to health plans, employers, and government agencies.
Exclusive sell-side advisor on the sale of fast-growing home infusion specialty pharmacy serving bleeding disorder and immunoglobulin patients in 20+ states.
Exclusive sell-side advisor on the sale of Dallas-based specialty pharmacy managing patients with complex, chronic, and rare disorders.
Exclusive sell-side advisor on the sale of Houston-based multi-disciplined specialty pharmacy serving chronic needs patients in 21 states.
Exclusive sell-side advisor on the sale of Oklahoma-based specialty pharmacy providing home and alternate-site infusion therapies.
French software provider and European leader in document design, composition, production management, and multi-channel delivery. Sold to French postal service.
Exclusive sell-side advisor on the sale of AI-first donor engagement solution for mid-level and major gift officers to leading Responsive Fundraising software provider.
Exclusive sell-side advisor on the sale of award-winning Property & Casualty reserving software solution to one of the world's largest actuarial and risk management consulting firms.
Cloud-based, fully integrated software platform revolutionizing non-life insurance pricing with Transparent AI.
Exclusive sell-side advisor on the sale of all-in-one campus experience management platform to Ready Education, a mobile-first student engagement platform backed by Level Equity. Combined entity serves 700+ institutions and 7M students.